These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12656907)

  • 1. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease.
    Prieto Castro RM; Leva Vallejo ME; Regueiro Lopez JC; Anglada Curado FJ; Alvarez Kindelan J; Requena Tapia MJ
    BJU Int; 2003 Apr; 91(6):522-4. PubMed ID: 12656907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
    Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
    J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
    Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M
    Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome.
    Kadioglu A; Tefekli A; Köksal T; Usta M; Erol H
    Int J Impot Res; 2000 Jun; 12(3):169-75. PubMed ID: 11045911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study.
    Safarinejad MR
    Int J Impot Res; 2004 Jun; 16(3):238-43. PubMed ID: 14973528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does smoking change the efficacy of combination therapy with vitamin E and colchicines in patients with early-stage Peyronie's disease?
    Cakan M; Demirel F; Aldemir M; Altug U
    Arch Androl; 2006; 52(1):21-7. PubMed ID: 16338865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conservative treatment of Peyronie's disease: colchicine vs. colchicine plus vitamin E].
    Cortés-González JR; Glina S
    Actas Urol Esp; 2010 May; 34(5):444-9. PubMed ID: 20470717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is colchicine effective in Peyronie's disease? A pilot study.
    Akkus E; Carrier S; Rehman J; Breza J; Kadioglu A; Lue TF
    Urology; 1994 Aug; 44(2):291-5. PubMed ID: 8048212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
    Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
    Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological therapy in patients diagnosed with Peyronie's disease.
    Halal AA; Geavlete P; Ceban E
    J Med Life; 2012 Jun; 5(2):192-5. PubMed ID: 22802890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
    Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
    Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study.
    Safarinejad MR; Hosseini SY; Kolahi AA
    J Urol; 2007 Oct; 178(4 Pt 1):1398-403; discussion 1403. PubMed ID: 17706714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.
    Paulis G; Brancato T; D'Ascenzo R; De Giorgio G; Nupieri P; Orsolini G; Alvaro R
    Andrology; 2013 Jan; 1(1):120-8. PubMed ID: 23258640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
    Paulis G; Brancato T
    Inflamm Allergy Drug Targets; 2012 Feb; 11(1):48-57. PubMed ID: 22309083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-partner satisfaction with intracavernous medication supported with oral agents in selected cases of Peyronie's disease. A ten-month follow-up study.
    Culha M; Mutlu N; Acar O; Alici B
    Int Urol Nephrol; 1999; 31(2):257-62. PubMed ID: 10481972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study.
    Paulis G; Cavallini G; Brancato T; Alvaro R
    Inflamm Allergy Drug Targets; 2013 Feb; 12(1):61-7. PubMed ID: 23004005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.
    Ziegelmann M; Savage J; Toussi A; Alom M; Yang D; Kohler T; Trost L
    J Urol; 2019 Sep; 202(3):599-610. PubMed ID: 30916626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series.
    Paulis G; De Giorgio G
    J Med Case Rep; 2022 Oct; 16(1):359. PubMed ID: 36207748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.